PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+15.99%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.57B
AUM Growth
+$240M
(+10%)
Cap. Flow
+$2.26M
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63
Top Buys
| 1 |
NVIDIA
NVDA
|
$23.5M |
| 2 |
Linde
LIN
|
$16.4M |
| 3 |
Broadcom
AVGO
|
$3.16M |
| 4 |
Advanced Micro Devices
AMD
|
$2.67M |
| 5 |
Qualcomm
QCOM
|
$1.54M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$6.7M |
| 2 |
Microsoft
MSFT
|
$5.59M |
| 3 |
Chevron
CVX
|
$4.56M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.45M |
| 5 |
Viking Therapeutics
VKTX
|
$3.77M |
Sector Composition
| 1 | Technology | 42.5% |
| 2 | Healthcare | 12.67% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Communication Services | 9.14% |
| 5 | Financials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vale
VALE
$44.4B
| $1.69M | 0.07% |
138,726
-24,155
| -15% | -$294K |
|
202
Sempra
SRE
$52.9B
| $1.69M | 0.07% |
23,486
-1,958
| -8% | -$141K |
|
203
Halozyme
HALO
$8.76B
| $1.68M | 0.07% |
41,346
-1,558
| -4% | -$63.4K |
|
204
United Therapeutics
UTHR
$18.1B
| $1.68M | 0.07% |
7,300
+35
| +0.5% | +$8.04K |
|
205
Cigna
CI
$81.5B
| $1.62M | 0.06% |
4,473
-529
| -11% | -$192K |
|
206
Pinterest
PINS
$25.8B
| $1.62M | 0.06% |
46,679
+3,894
| +9% | +$135K |
|
207
Crinetics Pharmaceuticals
CRNX
$3.35B
| $1.6M | 0.06% |
34,283
-5,851
| -15% | -$274K |
|
208
Charles Schwab
SCHW
$167B
| $1.6M | 0.06% |
22,157
+673
| +3% | +$48.7K |
|
209
Infosys
INFY
$67.9B
| $1.6M | 0.06% |
89,189
-106
| -0.1% | -$1.9K |
|
210
Exact Sciences
EXAS
$10.2B
| $1.6M | 0.06% |
23,130
+1,218
| +6% | +$84.1K |
|
211
Boston Scientific
BSX
$159B
| $1.59M | 0.06% |
23,181
-340
| -1% | -$23.3K |
|
212
Chubb
CB
$111B
| $1.56M | 0.06% |
6,034
+144
| +2% | +$37.3K |
|
213
Devon Energy
DVN
$22.1B
| $1.56M | 0.06% |
31,126
-10,266
| -25% | -$515K |
|
214
BridgeBio Pharma
BBIO
$10.2B
| $1.56M | 0.06% |
50,474
+4,127
| +9% | +$128K |
|
215
Marsh & McLennan
MMC
$100B
| $1.56M | 0.06% |
7,572
+938
| +14% | +$193K |
|
216
Lockheed Martin
LMT
$108B
| $1.56M | 0.06% |
3,424
+283
| +9% | +$129K |
|
|
BPMC
217
DELISTED
Blueprint Medicines
BPMC
| $1.55M | 0.06% |
16,375
-4,253
| -21% | -$403K |
|
218
Ecolab
ECL
$77.6B
| $1.55M | 0.06% |
6,710
+45
| +0.7% | +$10.4K |
|
|
WBA
219
DELISTED
Walgreens Boots Alliance
WBA
| $1.55M | 0.06% |
71,415
-10,050
| -12% | -$218K |
|
220
Madrigal Pharmaceuticals
MDGL
$9.65B
| $1.54M | 0.06% |
5,763
-1,397
| -20% | -$373K |
|
221
Alkermes
ALKS
$4.94B
| $1.54M | 0.06% |
56,848
-8,367
| -13% | -$226K |
|
222
Dominion Energy
D
$49.7B
| $1.54M | 0.06% |
31,228
-2,601
| -8% | -$128K |
|
223
CVS Health
CVS
$93.6B
| $1.54M | 0.06% |
19,251
-2,718
| -12% | -$217K |
|
224
Krystal Biotech
KRYS
$4.35B
| $1.52M | 0.06% |
8,553
-5,229
| -38% | -$930K |
|
225
Dyne Therapeutics
DYN
$2.02B
| $1.52M | 0.06% |
53,447
+26,485
| +98% | +$752K |
|